Maarten Uyttenboogaart

Optimizing Cutoff Scores for the Barthel Index and the Modified Rankin Scale for Defining Outcome in Acute Stroke Trials

Maarten Uyttenboogaart, Roy E. Stewart, Patrick C. Vroomen et al. · Stroke · 2005 · 307 citations · Full text

Medicine, Biostatistics, Neurology +17

Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

Susanne G. H. Olthuis, F.A.V. Pirson, Florentina M.E. Pinckaers et al. · The Lancet · 2023 · 237 citations · Full text

Medicine, Neurology, Surgery +16

Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis

Jonathan M. Coutinho, Susanna M. Zuurbier, Marie‐Germaine Bousser et al. · JAMA Neurology · 2020 · 221 citations · Full text

Medicine, Neurology, Surgery +13

Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial

Annette Compter, H. Bart van der Worp, Wouter J. Schonewille et al. · The Lancet Neurology · 2015 · 190 citations

Medicine, Surgery, Vascular Surgery +8

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

Raul G. Nogueira, Muhammad M. Qureshi, Mohamad Abdalkader et al. · Neurology · 2021 · 154 citations · Full text

Life Sciences, Health Sciences, Global Health +13